Latest News in the pharma Industry

All

New automated VPT systems for topical drug performance testing

New automated VPT systems for topical drug performance testing

11 Jan 2018

The MedStat-HT and MedFlux-HT help to de-risk development programs and shorten development timelines.

Read more 
BYDUREON BCise Injectable medicine now available in the US for type-2 diabetes patients

BYDUREON BCise Injectable medicine now available in the US for type-2 diabetes patients

11 Jan 2018

The new formulation is proven to reduce blood sugar levels and may have the added benefit of weight loss.

Read more 
3D human sebaceous glands technology for skin care applications

3D human sebaceous glands technology for skin care applications

9 Jan 2018

New 3D technology provides a powerful platform for skin care researchers wishing to study the function of sebaceous glands, in relation to a range of age-related, microbial and inflammatory skin disorders.

Read more 
Tjoapack investment triples its bottling capacity

Tjoapack investment triples its bottling capacity

8 Jan 2018

Companies outsourcing their packaging requirements - particularly those in the generics market where reducing time to market is crucial - look set to reap the benefits.

Read more 
Revolutionary medical innovations being unleashed in Canada MaRS discovery district

Revolutionary medical innovations being unleashed in Canada MaRS discovery district

7 Jan 2018

Health investors are paying attention to Canada, particularly to Toronto’s hot market.

Read more 
Takeda to acquire TiGenix

Takeda to acquire TiGenix

7 Jan 2018

Acquisition will expand Takeda’s late-stage pipeline and leadership in gastroenterology.

Read more 
Sangamo and Pfizer collaborate to develop zinc finger protein gene therapy for ALS

Sangamo and Pfizer collaborate to develop zinc finger protein gene therapy for ALS

7 Jan 2018

"The precision and flexibility of zinc finger proteins enables targeting of virtually any genetic mutation."

Read more 
Promacta receives FDA Breakthrough Therapy designation for first-line use in severe aplastic anemia

Promacta receives FDA Breakthrough Therapy designation for first-line use in severe aplastic anemia

4 Jan 2018

Data supporting designation showed over half of treatment-naïve SAA patients achieved complete response with Promacta when given with standard immunosuppressive therapy, with overall response rate of 85%.

Read more 
SSB to equip Abzena's US-based development and manufacturing sites

SSB to equip Abzena's US-based development and manufacturing sites

4 Jan 2018

SSB will provide both facilities with end-to-end process solutions in single-use format.

Read more 
Momenta and Mylan to development proposed biosimilar to Eylea

Momenta and Mylan to development proposed biosimilar to Eylea

4 Jan 2018

Targeting the initiation of a pivotal patient clinical trial in the first half of 2018.

Read more 
Junior Filters for space restricted applications

Junior Filters for space restricted applications

3 Jan 2018

Ideal for a wide variety of pharmaceutical applications.

Read more 
Novartis Kisqali receives FDA Breakthrough Therapy designation

Novartis Kisqali receives FDA Breakthrough Therapy designation

3 Jan 2018

Designation based on Phase III MONALEESA-7 results demonstrating superior efficacy of Kisqali in combination with oral endocrine therapy compared to oral endocrine therapy in pre- or perimenopausal women who received no prior endocrine therapy for adva...

Read more